New blood-based Alzheimer’s tests promise easier, more detailed diagnosis

At the recent Alzheimer’s Association International Conference, researchers presented advances that could make Alzheimer’s testing more widely available and informative.

Current diagnostic methods often require brain scans, spinal fluid analysis, or specialist‑administered cognitive exams, which can be costly and limited in capacity.

Scientists are developing blood‑based assays that aim to detect disease markers with a simple draw, offering a less invasive and potentially scalable solution while providing richer data on disease progression.

If these assays prove reliable, they may enable earlier detection and more personalized treatment strategies for patients.